Earnings History Data for TELESIS BIO (TBIO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

TELESIS BIO

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-03-2024	AH		TBIO	TELESIS BIO	13.00	-0.23	-0.25	0.00	Telesis Bio GAAP EPS of -$0.61, revenue of $7M [3/28/2024 5:03 PM]	0.44	-0.01 (-2.22%)	0.42	-0.02 (-3.41%)	0.30 - 3.32	28,860	110,000	13,126
Telesis Bio GAAP EPS of -$0.61, revenue of $7M [3/28/2024 5:03 PM]
13-11-2023	AH		TBIO	Telesis Bio, Inc.	20.39	-0.37	-0.28	-0.42	Telesis Bio GAAP EPS of -$0.37, revenue of $5.6M [11/13/2023 5:22 PM]	0.4988	0.0 (-0.26%)	0.0	0.0 (0.00%)	0.44 - 3.32	230,571	40,000	0
Telesis Bio GAAP EPS of -$0.37, revenue of $5.6M [11/13/2023 5:22 PM] Telesis Bio GAAP EPS of -$0.37 misses by $0.04, revenue of $5.6M misses by $1.8M [11/13/2023 5:34 PM]
10-08-2023	PM		TBIO	Telesis Bio, Inc.	38.91	-0.28	-0.27	-0.50	Codex DNA GAAP EPS of -$0.28 beats by $0.05, revenue of $8.65M beats by $1.25M [8/11/2023 9:58 AM]	1.31	-0.08 (-5.76%)	1.42	0.03 (2.16%)	1.08 - 3.32	102,337	90,000	3,202
Codex DNA GAAP EPS of -$0.28 beats by $0.05, revenue of $8.65M beats by $1.25M [8/11/2023 9:58 AM] BofA lowers rating on Telesis Bio to sector weight from overweight [8/11/2023 1:18 PM]
11-05-2023	AH	After the close (May 11)	TBIO	Telesis Bio, Inc.	80.94	-0.37	-0.38	-0.45	Codex DNA GAAP EPS of -$0.37 in-line, revenue of $6.31M misses by $1.09M [5/11/2023 4:19 PM]	2.57	-0.31 (-10.76%)	2.38	-0.50 (-17.36%)	1.08 - 4.72	136,980	40,000	13,358
Codex DNA GAAP EPS of -$0.37 in-line, revenue of $6.31M misses by $1.09M [5/11/2023 4:19 PM]
21-03-2023	AH	After the close (Mar 21)	TBIO	Telesis Bio, Inc.	50.78	-0.28	-0.32	-0.43	Codex DNA GAAP EPS of -$0.28 beats by $0.13, revenue of $9.47M beats by $2.27M [3/21/2023 4:56 PM]	2.08	-0.13 (-5.70%)	2.48	0.27 (12.22%)	1.08 - 9.80	6,144,094	80,000	97,386
Codex DNA GAAP EPS of -$0.28 beats by $0.13, revenue of $9.47M beats by $2.27M [3/21/2023 4:56 PM]
06-05-2021	AH		TBIO	Translate Bio, Inc.	1,670	-0.10	-0.09	-0.24	Translate Bio misses on revenue [5/6/2021 5:22 PM]	19.43	0.69 (3.68%)	18.75	0.01 (0.05%)	11.91 - 34.64	697,900	910,000	4,538
Translate Bio misses on revenue [5/6/2021 5:22 PM] Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [May-05-21 04:30PM] Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update [May-06-21 04:13PM] Translate Bio, Inc. (TBIO) Reports Q1 Loss, Misses Revenue Estimates [May-06-21 06:50PM]